Tekla Life Sciences Investors

Tekla Life Sciences Investors

HQL · NYSE · Financial Services / Asset Management

18.28USD-0.06 (-0.33%)

Price History

Full chart

Market Stats

Previous Close18.34
Open18.34
Day Range17.88 – 18.49
52-Week Range13.17 – 22.04
Volume105.66K
Market Cap585.96M
P/E (TTM)2.90
Forward P/E0.00
EPS6.64
Dividend Yield11.62%
Beta0.72
50-Day Avg20.34
200-Day Avg18.12

About

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEODr. Daniel R. Omstead M.S, Ph.D.
  • Employees0
  • Headquarters1900 Market Street, Philadelphia, PA, United States, 19103, USA
  • Websitehttps://www.teklacap.com/hql.html

Leadership

  • Dr. Daniel R. Omstead M.S, Ph.D.Principal Executive Officer, President and Trustee · b. 1953
  • Mr. Peter BrannerChief Investment Officer · b. 1964

Financials

Income Statement

Currency: USD1996-09-301997-09-301998-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue420.00K320.00K140.00K1.77M940.00K610.00K320.00K890.00K2.30M2.88M1.67M460.00K1.82M570.00K2.14M516.76K876.79K1.32M6.29M69.81M1.99M-69.34M124.08M65.69M-103.25M23.52M86.69M86.39M
Growth (%)--23.81%-56.25%+1164.29%-46.89%-35.11%-47.54%+178.13%+158.43%+25.22%-42.01%-72.46%+295.65%-68.68%+276.23%-75.90%+69.67%+50.85%+375.68%+1009.65%-97.16%-3591.86%+278.94%-47.06%-257.18%+122.78%+268.50%-0.35%
Cost of Revenue1.60M1.63M1.64M3.26M2.86M2.44M2.78M2.81M2.93M3.62M3.76M2.85M2.99M3.02M2.48M3.10M4.14M5.65M4.95M4.61M4.77M4.48M4.78M5.60M5.55M5.24M5.36M4.97M
Gross Profit-1.18M-1.31M-1.50M-1.49M-1.92M-1.83M-2.46M-1.92M-630.00K-740.00K-2.09M-2.39M-1.17M-2.45M-335.50K-2.58M-3.26M-4.33M1.34M65.20M1.99M-69.34M124.08M65.69M-103.25M23.52M86.69M86.39M
Gross Margin-280.95%-409.38%-1071.43%-84.18%-204.26%-300.00%-768.75%-215.73%-27.39%-25.69%-125.15%-519.57%-64.29%-429.82%-15.64%-499.89%-372.18%-327.02%21.34%93.40%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Expense290.00K220.00K250.00K450.00K600.00K510.00K610.00K670.00K710.00K970.00K830.00K760.00K790.00K1.35M947.92K586.72K502.56K397.04K5.13M69.08M5.59M1.14M1.03M1.16M1.35M1.17M1.39M791.57K
Operating Income-1.47M-1.53M-1.75M-1.94M-2.52M-2.34M-3.07M-2.59M-1.34M-1.71M-2.92M-3.15M-1.96M-3.80M-1.28M-3.17M-3.77M-4.72M-3.79M-3.88M-3.61M-70.48M123.05M64.53M-104.60M22.35M85.30M85.59M
Operating Margin-350.00%-478.13%-1250.00%-109.60%-268.09%-383.61%-959.38%-291.01%-58.26%-59.38%-174.85%-684.78%-107.69%-666.67%-59.85%-613.43%-429.50%-357.04%-60.25%-5.56%-181.64%101.64%99.17%98.24%101.31%95.02%98.40%99.08%
EBITDA21.81M15.19M-1.75M-1.94M-2.52M38.62M7.16M44.76M-1.34M50.51M60.25M-3.15M10.19M37.47M78.91M172.47M182.30M85.72M-20.03M68.56M60.94M-70.48M123.05M64.53M-104.60M22.35M87.22M85.59M
EBITDA Margin5192.86%4746.88%-1250.00%-109.60%-268.09%6331.15%2237.50%5029.21%-58.26%1753.82%3607.78%-684.78%559.89%6573.68%3679.80%33375.39%20791.80%6481.22%-318.42%98.20%3068.53%101.64%99.17%98.24%101.31%95.02%100.61%99.08%
Net Income21.81M15.19M-30.38M-95.03M-50.41M38.62M7.16M44.76M-21.44M50.51M60.25M-21.67M10.19M37.47M77.63M84.65M89.27M40.50M-11.91M68.56M28.66M-70.48M123.05M64.53M-104.60M22.35M85.30M85.59M
Net Income Margin5192.86%4746.88%-21700.00%-5368.93%-5362.77%6331.15%2237.50%5029.21%-932.17%1753.82%3607.78%-4710.87%559.89%6573.68%3619.95%16380.07%10181.17%3062.09%-189.30%98.20%1443.44%101.64%99.17%98.24%101.31%95.02%98.40%99.08%
R&D------------------1.891.46--3.151.433.280.57--
R&D as % of Total Revenue------------------0.00%0.00%--0.00%0.00%-0.00%0.00%--
Interest Expense0000000000000078.91M87.82M93.03M45.22M8.12M72.43M32.27M67.60M00----
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3679.64%16994.42%10610.32%3419.13%129.08%103.76%1625.09%-97.49%0.00%0.00%----

Balance Sheet

Currency: USD1996-09-301997-09-301998-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets123.70M132.20M101.40M215.90M157.90M193.00M193.10M230.30M270.80M309.10M281.00M265.10M256.80M171.60M227.48M302.82M444.84M467.85M417.63M468.33M478.47M386.98M484.17M534.19M414.73M402.60M460.58M515.38M
Total Liabilities600.00K200.00K1.40M800.00K300.00K2.60M1.30M1.00M2.70M1.10M3.20M16.50M5.40M1.00M404.67K530.12K754.55K5.01M2.66M1.98M2.98M2.82M595.18K10.75M16.82M666.96K888.61K1.73M
Total Equity123.10M132.00M100.00M215.20M157.60M190.40M191.80M229.30M268.10M308.00M277.80M248.60M251.40M170.60M227.08M302.29M444.09M462.84M414.97M466.35M475.49M383.65M483.57M523.44M397.90M401.93M459.69M513.66M
Cash200.00K100.00K-400.00K100.00K1.10M700.00K-1.45K6722185.50M--68936.58K2.34K40310.07K615.31K411.12M-4.97M990445477175.54K
Total Debt----------------------26.03K1.34M11.09M---
Net Debt-200.00K-100.00K--400.00K-100.00K-1.10M-700.00K-----5.50M---689-36.58K-2.34K-403-10.07K-615.31K-41-1.12M4.99M1.34M10.65K-477-1-75.54K

Cash Flow

Currency: USD1996-09-301997-09-301998-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-1.50M-1.50M-1.70M-1.90M-2.60M-2.40M-3.20M-3.20M-2.10M-3.70M11.80M13.00M1.90M118.30M21.11M9.47K-52.57K-----0.62--0.74----2.32M
Investing Cash Flow500.00K7.80M2.00M10.20M9.60M9.30M8.50M9.80M-58.20M14.30M-----------------25.21M
Financing Cash Flow--6.30M-1.60M-8.10M-7.20M-5.90M-5.70M-7.30M60.30M-10.60M-11.80M-7.60M-7.30M-118.30M-21.10M-9.44K52.53K-----------31.63M
Capital Expenditure0000000000000000000000000005
Free Cash Flow-1.50M-1.50M-1.70M-1.90M-2.60M-2.40M-3.20M-3.20M-2.10M-3.70M11.80M13.00M1.90M118.30M21.11M9.47K-52.57K-----0.62--0.74----2.32M
Dividends Paid-6.30M1.60M8.10M7.20M5.90M5.70M7.30M11.10M10.60M11.80M7.60M3.60M11.20M10.23M9.44K13.96K----------31.63M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%----100.00%-100.00%---100.00%
Dividend Paid to FCF--420.00%-94.12%-426.32%-276.92%-245.83%-178.13%-228.13%-528.57%-286.49%100.00%58.46%189.47%9.47%48.46%99.62%-26.56%-----------1363.32%

Earnings

Report DateDec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 3, 2016Sep 30, 2016Dec 1, 2016Mar 31, 2017Jun 2, 2017Sep 30, 2017Dec 5, 2017Mar 31, 2018Jun 1, 2018Sep 30, 2018Dec 4, 2018Mar 31, 2019Jun 5, 2019Sep 30, 2019Dec 5, 2019Mar 31, 2020Jun 5, 2020Sep 30, 2020Dec 4, 2020Mar 31, 2021Jun 4, 2021Sep 30, 2021Dec 3, 2021Jun 3, 2022Dec 7, 2022Dec 9, 2024Jun 9, 2025Dec 8, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00
EPS Actual0.970.97-0.19-0.191.921.920.800.800.880.881.961.961.161.161.411.412.362.36-1.28-1.28-1.72-1.72-3.441.382.690.631.270.971.90-0.45-0.901.082.12-0.86-1.72-0.68-1.330.641.291.943.830.651.300.671.32-3.03-1.081.22-1.644.38
Surprise--------------------------------------------------
Timing------------------------------------------------After-hours-

Key Statistics & Ratios

Market Cap585.96M
Enterprise Value585.11M
Trailing P/E2.90
Forward P/E0.00
PEG Ratio0.00
Price / Sales528.01
Price / Book1.06
EPS6.64
Book Value18.44
Revenue (TTM)1.11M
Gross Profit (TTM)1.11M
Profit Margin17856.98%
Operating Margin-516.53%
Return on Equity41.43%
Return on Assets-0.61%
Shares Outstanding30.41M
Shares Float0
Beta0.72
Dividend Yield11.62%
Dividend Rate2.24
Payout Ratio51.14%

Dividends

20263×
0.62Aug 24, 20260.56May 21, 20260.56Feb 20, 2026
20254×
0.50Nov 21, 20250.42Aug 22, 20250.43May 22, 20250.47Feb 21, 2025
20244×
0.50Nov 21, 20240.49Aug 23, 20240.48May 22, 20240.39Feb 21, 2024
20234×
0.30Nov 21, 20230.32Aug 24, 20230.32May 24, 20230.33Feb 24, 2023
20224×
0.31Nov 23, 20220.31Aug 25, 20220.35May 26, 20220.39Feb 24, 2022
20214×
0.42Nov 23, 20210.43Aug 26, 20210.41May 27, 20210.43Feb 25, 2021
20201×
0.02Dec 30, 2020